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The coordinated activities of many protein kinases, acting on multiple protein substrates, 13 
ensures the error-free progression through mitosis of eukaryotic cells. Enormous research 14 
effort has thus been devoted to studying the roles and regulation of these mitotic kinases, 15 
and to the identification of their physiological substrates. Central for the timely deployment 16 
of specific protein kinases to their appropriate substrates during the cell division cycle are the 17 
many anchoring proteins, which serve critical regulatory roles. Through direct association, 18 
anchoring proteins are capable of modulating the catalytic activity and/or sub-cellular 19 
distribution of the mitotic kinases they associate with. The key roles of some anchoring 20 
proteins in cell division are well-established, whilst others are still being unearthed. Here, we 21 
review the current knowledge on anchoring proteins for some mitotic kinases, and highlight 22 
how targeting anchoring proteins for inhibition, instead of the mitotic kinases themselves, 23 




Accurate execution of the cell division cycle results in the precise duplication and subsequent 28 
separation of DNA and cytoplasm into two newly-formed daughter cells. The cell cycle is 29 
conventionally divided into two main phases: interphase, where the cell prepares for division, 30 
and M phase, where the cell divides into two genetically-identical daughter cells. Multiple 31 
regulatory checkpoints exist in cells to ensure that the cell cycle progresses with precision and 32 
accuracy, as errors at any point can be detrimental to the cell and organism as a whole (1-3). 33 
Indeed, many disease states, most notably cancer, have been linked to aberrant cell cycle 34 
control (2, 4, 5). Deciphering the regulatory nodes of the cell cycle is thus a topic of wide 35 
research interest, from both a basic science and therapeutic perspective. 36 
 37 
Of the post-translational modifications known to regulate the cell cycle, protein 38 
phosphorylation constitutes one of the most studied to date. This phosphorylation-centred 39 
mitotic research focus likely stems from observations that the entry into mitosis is 40 
accompanied by a profound increase in the level of protein phosphorylation throughout the 41 
 2 
cell (2, 6, 7). Historically, the observation that protein phosphorylation was dramatically 1 
increased following entry into mitosis was a key cornerstone in the identification of 2 
maturation promoting factor (MPF) – a cytoplasmic factor first identified in Xenopus oocytes,  3 
capable of stimulating entry into M-phase of the cell cycle (8, 9). MPF was later shown to 4 
consist of a protein kinase we now refer to as Cyclin-Dependent Kinase 1 (CDK1), and its 5 
associated regulatory subunit Cyclin (10). Since then, several other protein kinases have been 6 
found to have instrumental roles in eukaryotic cell division, and enormous effort has been 7 
devoted to understanding the roles of these protein kinases in mitosis, and to the 8 
identification of their physiological substrates. Indeed, many studies have determined the 9 
critical roles protein phosphorylation plays in key mitotic processes, including chromosome 10 
condensation and mitotic spindle assembly (11). 11 
 12 
However, mitotic kinases require strict spatiotemporal regulation in order to exert their 13 
effects on the cell cycle. Indeed, many mitotic kinases exhibit dynamic changes in their 14 
subcellular distribution as mitosis progresses, or simultaneously reside at distinct mitotic 15 
structures such as centrosomes and kinetochores. The vital roles of anchoring proteins 16 
[defined in relation to other accessory binding proteins in Box 1 (12)] in these processes, 17 
acting to spatiotemporally coordinate mitotic kinase recruitment to key subcellular 18 
structures, and hence their substrates, are critically important for an accurate cell division. 19 
Here, we review the best-characterised anchoring proteins for some mitotic kinases, and 20 
summarise the mounting evidence supporting crucial roles for these diverse signalling 21 
proteins in coordinating the cell division cycle. 22 
 23 
Cyclins control CDKs, the master regulators of the cell cycle 24 
 25 
Cyclin-dependent kinases (CDKs) are a family of Ser/Thr protein kinases, whose catalytic 26 
activity depends on regulatory subunits termed Cyclins. This opening statement is a 27 
culmination of decades of research efforts that established that CDKs are indeed, as their 28 
name suggests, Cyclin-dependent. The identification of MPF (9) was a crucial first step in the 29 
subsequent determination of CDK-Cyclin interplay during mitosis. Although MPF was 30 
identified in 1971, the discovery of the MPF catalytic component did not come until 1988 31 
when a purified MPF preparation from Xenopus oocytes was shown to contain two major 32 
proteins of 32 kDa and 45 kDa masses respectively (10). One year prior, homologs of the Cdc2 33 
protein kinase were shown to be functionally conserved from yeast to humans (13): Cdc2 was 34 
originally identified in genetic screens searching for yeast mutants with defects in cell division 35 
(14, 15), and Cdc2 was later shown to be essential for cell-cycle progression (16). As Cdc2 was 36 
also a 32 kDa mitotic protein, it was speculated that the 32 kDa protein present in MPF 37 
purifications may be a Xenopus homolog of Cdc2. Consistent with this idea, an antibody 38 
recognising a conserved 16 amino acid sequence of Cdc2 was capable of depleting the purified 39 
MPF preparation of its MPF activity (17). Importantly, this antibody immunoprecipitated both 40 
 3 
the 45 kDa and the 32 kDa proteins present in the MPF preparation (17), suggesting that Cdc2 1 
and an associated protein may constitute the functional MPF complex.  2 
 3 
Simultaneously, independent studies in sea urchin oocytes led to the identification of some 4 
proteins that were synthesised and degraded at each cleavage division (18). Due to this 5 
cyclical nature in their expression, these proteins were termed Cyclins. Subsequently, Cyclins 6 
were cloned from fertilised clam embryos, and the ectopic introduction of Cyclin A mRNA was 7 
shown to promote meiosis in Xenopus oocytes, suggesting that a rise in Cyclin A may drive 8 
progression into M phase (19). The biochemical connection between Cdc2 and Cyclins came 9 
in 1989 when researchers determined that Cdc2 associates with Cyclin A and B in starfish, 10 
clam and Xenopus oocytes (20-22). Thus, Cdc2 thereafter became known as Cyclin-dependent 11 
Kinase 1 (CDK1). At this time, it was also proposed that Cyclin proteolysis may drive 12 
inactivation of the associated CDK (20), thereby promoting the idea that mitotic kinase 13 
activity could be regulated by interacting proteins in cells.  14 
 15 
With the advent of cDNA libraries and Polymerase Chain Reaction (PCR) technology, many 16 
other CDK family members were identified, and their role as critical regulators of eukaryotic 17 
cell division began to be fully appreciated (23-26). To date, 20 members of the CDK family 18 
have been identified, and these have been designated CDK1-CDK20 (27). Decades of 19 
molecular research have now determined that A-type Cyclins bind CDK1 and CDK2 and these 20 
CDK-Cyclin A complexes act to resolve S phase and promote entry into the G2 phase (28). 21 
During G2, A-type Cyclins are degraded through ubiquitin-mediated proteolysis, and the B-22 
type Cyclins are actively synthesised. Consequently, CDK1 associates with the newly-23 
translated Cyclin B and this active complex is thought to regulate several key steps during the 24 
G2/M transition (11, 28). Many substrates have been reported for CDK1-Cyclin B during this 25 
transition, including histones, whose phosphorylation by CDK1 promotes chromosome 26 
condensation, and lamins, whose phosphorylation triggers nuclear envelope breakdown 27 
(NEBD). Notably, CDK1-Cyclin B complexes have been shown to localise to centrosomes 28 
during prophase, and phosphorylate the motor protein Eg5 in order to promote centrosome 29 
separation (11). CDK1 has also been shown to activate several other mitotic protein kinases 30 
(11, 28), and as such, CDK1 is often regarded as the master mitotic kinase. Furthermore, the 31 
inactivation of CDK1-Cyclin B complexes is required for mitotic exit, and this inactivation is 32 
achieved through the proteasomal degradation of Cyclin B following its ubiquitination by the 33 
anaphase-promoting complex E3 ligase, leaving behind inactive, isolated CDK1 in the process 34 
(1, 29).  35 
 36 
Cyclins are also key mediators of CDK localisation during the cell cycle. In both humans and 37 
Xenopus, Cyclin A, and thus the CDK1-Cyclin A complex, is found within the nucleus from S-38 
phase until the breakdown of the nuclear envelope (30, 31). Cyclin B and its associated CDK1 39 
partner, on the other hand, is cytoplasmic in G2 and enters the nucleus just prior to NEBD 40 
(30, 31). Cyclin B possesses a nuclear export signal, and this signal maintains Cyclin B in the 41 
 4 
cytoplasm during interphase (32-35). Following NEBD, CDK1-Cyclin B is found on the spindle 1 
apparatus as well as on condensed chromosomes (30). These differences in Cyclin localisation 2 
are thought to underpin CDK1 substrate specificity in vivo. A pioneering study sought to 3 
determine whether it was the availability of a Cyclin within a subcellular compartment that 4 
was the limiting step in the cell cycle-dependent regulation of localised CDK activity. 5 
Expression of a Cyclin B1 mutant protein lacking its intrinsic nuclear export signal led to 6 
retention of Cyclin B1 in the nucleus, and this mutant protein was capable of stimulating DNA 7 
synthesis even in the absence of the native DNA synthesis-promoting Cyclin, Cyclin E (36). 8 
Thus, the spatial proximity and availability of Cyclins to CDKs appears to be critical for the 9 
spatiotemporal regulation of localised CDK activity. Phosphorylation of Cyclin B in prophase 10 
was found to regulate the nuclear translocation of Cyclin B in prophase, and a mitotic kinase 11 
termed Polo-like Kinase 1 (discussed in detail in the subsequent sections) was found to be the 12 
kinase responsible for this key mitotic event (37). Intriguingly, a related Cyclin termed Cyclin 13 
F was shown to be required for the nuclear translocation of Cyclin B, in a manner dependent 14 
on the intrinsic nuclear localisation signals of Cyclin F (38). This was the first example of a 15 
Cyclin-Cyclin protein interaction (38). 16 
 17 
Interestingly, indicative of a potential role in regulating microtubule attachments or spindle 18 
assembly checkpoint signalling, Cyclin B1 was later found to reside at kinetochores (39, 40). 19 
Recently, two independent studies have highlighted the role of the spindle assembly 20 
checkpoint protein Mad1 in promoting CDK1-Cyclin B1 recruitment to kinetochores (41, 42). 21 
In stark contrast, the related B-type Cyclin, Cyclin B2, localises to the Golgi apparatus to 22 
enforce CDK1-mediated disassembly of this organelle during mitosis (43, 44). Interestingly, a 23 
chimeric protein composed of the N-terminus of Cyclin B2 and the C-terminus of Cyclin B1 24 
was shown to associate with the Golgi apparatus, suggesting that the N-termini of Cyclins may 25 
determine their localisation patterns in cells (43). Importantly, this chimeric Cyclin did not 26 
show reduced binding to CDK1, nor did it affect CDK1 activation, when compared with wild-27 
type Cyclins (43). 28 
 29 
Future efforts aimed at determining the interacting partners of specific Cyclins may shed light 30 
on how these critical CDK1 regulators are controlled and recruited to specific subcellular 31 
compartments, where the associated CDKs act during the cell division cycle. However, it 32 
should be noted that Cyclin-interacting proteins are unlikely to fully explain the control of 33 
CDK1-Cyclin localisation. Indeed, phosphorylation of Cyclin B has been shown to be important 34 
for retaining Cyclin B in the cytoplasm (37, 45), and the binding of Cyclin B to the nuclear 35 
export regulating protein CRM1 (Chromosome Region Maintenance 1 protein homolog) has 36 
also been established as a key regulatory mechanism of Cyclin B nuclear translocation (32).   37 
 38 
Anchoring proteins regulating Aurora kinases: an exemplar relationship 39 
 40 
 5 
The aurora gene was first identified in a Drosophila screen aimed at identifying genes whose 1 
products could control cell cycle progression (46, 47). With the discovery of homologs in other 2 
species, the Aurora kinases have emerged as central players in cell division (48). Aurora 3 
kinases are highly conserved, and present with a similar domain architecture between 4 
homologs (49). Aurora kinases possess a Ser/Thr protein kinase domain sandwiched between 5 
N- and C-terminal domains (50). The N- and C- terminal domains are thought to be important 6 
in regulating Aurora kinase stability, as well as in determining the interaction partners of 7 
distinct Aurora kinases (50). In humans, there are three Aurora kinases, designated AURKA, B 8 
and C, and they display distinct subcellular distributions (11). AURKA localises to the 9 
duplicated centrosomes at the start of S phase, and shifts to bipolar spindle microtubules 10 
during mitosis (51, 52). AURKB localises to chromosomes in prophase and the centromere in 11 
prometaphase, before shifting to the central spindle in anaphase and the mid-body in 12 
cytokinesis (51, 52). The least-studied family member, AURKC, is localised to chromosomes 13 
during mitosis and is thought to enhance AURKB function, but, unlike AURKA and B, is 14 
principally expressed in the male and female germline of mammals (48, 53).   15 
 16 
The ability of Aurora kinases to achieve such diverse localisation patterns during mitosis is 17 
determined through the binding to different regulatory anchoring proteins. For example, 18 
following NEBD, AURKA is recruited to spindle microtubules by binding the microtubule-19 
associated protein Targeting Protein for Xklp2 (TPX2), where TPX2 serves the additional 20 
purpose of allosterically activating AURKA (48, 54, 55) (Figure 1A). TPX2 also contributes to 21 
full AURKA activation by shielding it from inhibitory dephosphorylation by Protein 22 
Phosphatase 1 (PP1) (56, 57). Crucially, TPX2 localisation to spindle microtubules is 23 
independent of its interaction with AURKA, consistent with the idea that TPX2 recruits AURKA 24 
to the spindle to regulate spindle assembly and spindle microtubule dynamics (58). Indeed, 25 
the AURKA-TPX2 interaction was shown to be critically important for the assembly of spindles 26 
of correct length, and for faithful chromosome segregation (58). Furthermore, the AURKA-27 
TPX2 interaction was shown to be important for AURKA stability (59). TPX2-silenced U2OS 28 
cells showed lower AURKA protein levels in G2 and prometaphase, whereas overexpression 29 
of the AURKA-binding domain of TPX2 blocked AURKA degradation in telophase (59). Adding 30 
more complexity to the AURKA-TPX2 interaction, TPX2 itself appears to be an AURKA 31 
substrate. In Xenopus, TPX2 was phosphorylated by AURKA (56, 60), and in HeLa cells AURKA-32 
phosphorylated TPX2 was shown to regulate spindle length (61).  33 
 34 
AURKA also localises to centrosomes throughout the cell cycle. The localisation of AURKA to 35 
centrosomes was shown to be dependent on the protein Bora (Figure 1A), a highly-conserved 36 
AURKA-interacting protein originally identified based on phenotypic similarities - both AURKA 37 
and Bora mutants exhibited identical centrosome maturation defects (62). The AURKA-Bora 38 
complex was suggested to be the kinase complex responsible for phosphorylating and 39 
activating PLK1 (63), a key mitotic kinase required for centrosome maturation and spindle 40 
formation. Bora-depleted cells present with multipolar mitotic spindles - an effect 41 
 6 
reminiscent of TPX2 knockdown (58). Although the recruitment of AURKA to centrosomes is 1 
dependent on Bora, whether Bora achieves this in a direct or indirect manner remains to be 2 
determined. Regardless, Bora is thought to be a key AURKA activator in cells (62). However, 3 
it should be noted that Bora doesn’t appear to enhance AURKA activity per se, but rather acts 4 
to make the activation loop of PLK1 more accessible for phosphorylation by AURKA (64). Thus, 5 
in the context of AURKA-dependent PLK1 phosphorylation, Bora can be considered an AURKA 6 
activating protein, but the in vitro AURKA activity immunoprecipitated with Bora is far less 7 
than the AURKA activity isolated in TPX2 immunoprecipitates (65). Once cells entered mitosis, 8 
Bora was shown to be phosphorylated and degraded in a PLK1-depenent manner, and this 9 
phosphodegron event is thought to be a prerequisite for the recruitment of AURKA to spindle 10 
microtubules by TPX2 (65) (Figure 1A).  11 
 12 
AURKB, on the other hand, is a component of the Chromosome Passenger Complex (CPC), 13 
which consists of three non-enzymatic AURKB-regulatory proteins termed INner CENtromere 14 
Protein (INCENP), Borealin and Survivin (66-69) (Figure 1B). INCENP, Borealin and Survivin all 15 
act as both targeting and activating subunits of AURKB (66-68), although the evidence in 16 
favour of Survivin being a bona fide AURKB-activating protein remains controversial (70, 71). 17 
Interestingly, formation of the CPC appears to be essential for the stability of individual 18 
proteins within the complex (66, 70). The CPC, and hence AURKB activity, has been linked to 19 
the correction of microtubule-chromosome attachment errors and activation of the spindle 20 
assembly checkpoint (67).  21 
 22 
As described earlier, the CPC exhibits a very dynamic localisation profile during cell division, 23 
and this change in localisation is largely thought to coordinate AURKB activity towards its 24 
substrates during mitosis. Importantly, when either INCENP, Survivin or Borealin are 25 
mislocalised, the other complex members also mislocalise (66, 70, 72-74). At the onset of 26 
mitosis, the CPC localises to chromosomes, and in prometaphase to inner centromeres (51, 27 
52, 67). During the metaphase-to-anaphase transition, the CPC is found on central spindle 28 
microtubules, before concentrating at the midbody during the latter stages of cell division 29 
(51, 52, 67). INCENP acts as the platform on which the CPC is assembled, and the N-terminus 30 
of INCENP mediates CPC recruitment to centromeres (75). Biochemical studies determined 31 
that it was the first 58 amino acids of INCENP that are required for binding to Borealin and 32 
Survivin, and are critical for the localisation of the CPC to the centromere, spindle midzone 33 
and midbody (66, 75, 76). Crucially, this dynamic localisation profile correlates with the 34 
pleiotropic functions of the CPC during cell division, and thus provides an elegant example of 35 
how mitotic kinase anchoring proteins can facilitate the many functions of their associated 36 
kinase partners, simply by coordinating the sub-cellular distribution of that kinase. 37 
Interestingly, a single amino acid change in human AURKA (G198N – AURKB has an Asn at the 38 
equivalent residue to G198) renders the kinase AURKB-like, promoting localisation to 39 
chromosomes and interaction with INCENP and Survivin. Intriguingly, this AURKA mutant was 40 
able to rescue mitotic defects resulting from AURKB knockdown (77, 78).  41 
 7 
 1 
The importance of Survivin in localising the CPC to chromatin is well-established. Following 2 
phosphorylation of Histone H3 on Thr3 by the Ser/Thr protein kinase Haspin, Survivin binds 3 
phospho-Histone H3 (Thr3), and acts to recruit the CPC to chromosomes, where AURKB is 4 
activated and phosphorylates Histone H3 on Ser10 to regulate chromosome condensation 5 
(79) (Figure 1B). Crucially, Survivin was capable of binding phospho-Histone H3 (Thr3) in the 6 
absence of the other CPC proteins, strongly suggesting that Survivin is the CPC component 7 
that mediates CPC recruitment to chromatin (79). In late mitosis, when the Haspin site on 8 
Histone H3 is dephosphorylated, CPC localisation to chromatin is also suppressed, and thus 9 
this dephosphorylation event is thought to be key for the redistribution of the CPC as mitosis 10 
progresses (79-81). Curiously, whilst the majority of the CPC components exist in a quaternary 11 
complex to coordinate the functions of the CPC, a second complex consisting of solely AURKB 12 
and INCENP was proposed as an additional AURKB complex, functioning to regulate Histone 13 
H3 Ser10 phosphorylation (72). However, whether this sub-complex is merely an 14 
intermediate in the assembly of the full CPC cannot, at present, be ruled out.  15 
 16 
During the metaphase-to-anaphase transition, the CPC relocalises from the inner centromere 17 
to central spindle microtubules. This relocalisation event is associated with a decrease in 18 
CDK1 activity, and is dependent on both AURKB and phosphatase catalytic activity (82-84). 19 
Mechanistically, the kinesin-6 protein MKLP2 (Mitotic Kinesin-like Protein 2), which binds 20 
central spindle microtubules, associates with INCENP and AURKB to direct the CPC to the 21 
central spindle (82, 85, 86) (Figure 1B). This interaction only occurs in anaphase, once the 22 
inhibitory CDK1-mediated phosphorylation of MKLP2 is reduced (82) (Figure 1B). 23 
Interestingly, MKLP2 also binds and directs the phosphatase Cdc14A to central spindle 24 
microtubules, and Cdc14A has been proposed to dephosphorylate INCENP to promote to 25 
relocalisation of the CPC to the central spindle in anaphase (85).  26 
 27 
The Polo Box Domain – a unique mode for mitotic kinase recruitment 28 
 29 
Polo-like Kinases (PLKs) are a family of Ser/Thr protein kinases that were first described in 30 
lower eukaryotes (87, 88). In Drosophila melanogaster, a mutant of the protein Polo was 31 
found to present with defects in mitosis (88), and PLK homologs were subsequently identified 32 
in mammals (89). All PLKs have a similar domain architecture, with an N-terminal kinase 33 
domain, and a C-terminal regulatory Polo Box domain containing two signature motifs termed 34 
“Polo boxes” (89) (Figure 2A). Humans have 5 PLK enzymes termed PLK1-5, however the exact 35 
role and contribution of each PLK isoform is not well understood (89). As PLK1 is largely 36 
thought to mediate most of the mitotic functions attributed to the D. melanogaster Polo, the 37 
major focus of the subsequent section will be on PLK1. However, key roles for the related 38 
kinase PLK4 in centriole duplication have also been reported in recent years, and as such, the 39 
mitotic functions of PLK4 will also be discussed. 40 
 41 
 8 
Similar to many other protein kinases, human PLK1 is activated through phosphorylation 1 
within its T-loop (at Thr210), by an upstream protein kinase (90-92). As described earlier, the 2 
AURKA-Bora complex has been reported to phosphorylate and activate PLK1 in cells (63) 3 
(Figure 2B), although other upstream kinases have also been implicated (93). Emerging as a 4 
key regulatory feature of PLK1 in cells, the polo boxes have been shown to be instrumental in 5 
mediating PLK localisation (94-97). The Polo-box Domain (PBD) of PLK1 acts as a 6 
phosphopeptide-binding motif, and in this capacity, the PBD binds specific phosphorylated 7 
proteins to facilitate the recruitment of PLK1 to those proteins. The priming phosphorylation 8 
event on the target protein, which generates the phosphoepitope onto which the PBD binds, 9 
can be mediated by different protein kinases, allowing for wider crosstalk between different 10 
kinases during mitosis, but is most frequently performed by CDK1 or PLK1 itself (98-101) 11 
(Figure 2B). In cases where the phosphorylated PLK1-anchoring proteins are localised to 12 
cellular structures, such as kinetochores and centrosomes, PBD-mediated binding also 13 
imparts spatial control on PLK1 (102-105). To date, many such PBD-binding proteins have 14 
been identified (106). In the absence of a phosphoepitope to bind to, the PBD is thought to 15 
associate with the kinase domain of PLK1, thereby impeding its kinase activation and 16 
substrate binding (99). However, upon PBD-phosphoepitope association, the kinase domain 17 
is thought to be released from the PBD, and together with T-loop phosphorylation by 18 
upstream kinases, PLK1 achieves maximal activation. Simultaneously, the PBD-19 
phosphoepitope association determines where within the cell PLK1 is localised, and hence 20 
where its activity is utilised (99)  21 
 22 
In both interphase and mitosis, PLK1 localises to centrosomes, and centrosome-localised PLK1 23 
in mitosis has been reported to be critical for spindle pole formation, and positioning of the 24 
mitotic spindle (107, 108). Interestingly, following inhibition of PLK1, monopolar spindles 25 
form due to defective centrosome separation, and cells arrest in mitosis (107, 108). Whilst 26 
the exact PLK1-dependent substrate landscape is not fully elucidated, many proteins involved 27 
in centrosome function and microtubule dynamics have been reported to be PLK1 targets 28 
(106, 109). Recently, the pericentriolar material-localised protein Gravin was shown to be a 29 
PLK1 anchoring protein in cells (110) (Figure 2C). In vitro studies suggested that PLK1 30 
associated with Gravin only when Gravin was phosphorylated on Thr766 (111), suggesting a 31 
canonical PBD-mediated mode of interaction. Loss of Gravin in primary prostate cancer cells 32 
was associated with elevated micronuclei formation, and a redistribution of active PLK1 to 33 
different protein complexes within centrosomes (110). Interestingly, Gravin was also shown 34 
to interact with AURKA (112), suggesting that Gravin may act to streamline AURKA-PLK1 35 
signalling at centrosomes, similar to the Bora protein discussed earlier (Figure 2C). The Gravin-36 
PLK1-AURKA complex was shown to be down-regulated in human testicular seminoma (112), 37 
suggesting that disruption of this signalling axis may contribute to the disease. In a similar 38 
vein, it is also interesting to note that the centrosome-localised coiled-coil protein Cep192 39 
was also shown to act as a scaffold protein for both PLK1 and AURKA, and this macromolecular 40 
complex was critical for centrosome maturation (113) (Figure 2C). However, the 41 
 9 
phosphoepitope-generating residue of Cep192, Thr46, that facilitates PLK1 binding through 1 
its PBD, does not conform to a CDK1 consensus motif and is thought to be phosphorylated by 2 
PLK1 itself (113). As Gravin and Cep192 appear to act in similar capacities, it will be interesting 3 
to decipher the centrosomal PLK1/AURKA substrates that are dependent on, and unique to, 4 
each anchoring protein. Interestingly, the mother centriole-associated protein Cenexin has 5 
also been shown to associate with PLK1, following phosphorylation of Cenexin at Ser796 by 6 
CDK1 (114) (Figure 2C). The PLK1-Cenexin interaction was shown to be required for 7 
recruitment of pericentriolar material proteins, and thus maturation of centrosomes (114). 8 
 9 
In mitotic cells undergoing the metaphase-to-anaphase transition, PLK1 also localises to 10 
kinetochores, the centromere-associated protein complexes to which microtubules attach 11 
(89, 102). Kinetochores can sense when K-fibre microtubules are unattached to 12 
chromosomes, and even a single unattached chromosome can trigger a checkpoint 13 
mechanism known as the Spindle Assembly Checkpoint (SAC) (115). The localisation of PLK1 14 
to kinetochores thus suggests a role for PLK1 in kinetochore assembly, regulation of 15 
kinetochore-microtubule connections, and/or modulation of the SAC. A number of 16 
kinetochore-localised proteins have been implicated in the recruitment of PLK1 to 17 
kinetochores. For example, the SAC protein Bub1 was shown to bind PLK1 in a CDK1-18 
dependent manner, and depletion of Bub1 with siRNA was accompanied with a reduction in 19 
PLK1 at kinetochores (116) (Figure 2D). In line with this, overexpression of wild-type Bub1, 20 
but not the Bub1-T609A mutant that cannot be phosphorylated by CDK1, restored PLK1 21 
localisation in Bub1-silenced cells (116). Additionally, the outer kinetochore-associated 22 
protein CLIP-170 (Cytoplasmic Linker Protein 170) was shown to be required for PLK1 23 
kinetochore association, again following CDK1-mediated phosphorylation of CLIP-170 to 24 
promote the PLK1-CLIP-170 interaction (117) (Figure 2D). Depletion of CLIP-170 resulted in 25 
chromosome congression defects and kinetochore microtubule instability (117). The dynein-26 
associated protein dynactin was also found to facilitate PLK1 targeting to kinetochores, again 27 
in a CDK1-dependent manner (118) (Figure 2D). Thus, the recurring theme in the kinetochore 28 
recruitment of PLK1 appears to be CDK1-mediated phosphorylation of a target protein that 29 
then recruits PLK1 through PBD binding. However, whether this holds true for all PLK1-30 
recruiting proteins remains to be determined. Indeed, PLK1 is also reported to be localised to 31 
the midbody (119). As CDK1-Cyclin B activity would be abolished at this stage of mitosis, there 32 
is scope for other mitotic kinases, and for PLK1 itself, in promoting PBD-dependent 33 
recruitment of PLK1 at the latter stages of cell division. 34 
 35 
During anaphase, PLK1 also localises to central spindle microtubules. The PLK1 anchoring 36 
protein PRC1 (Protein Regulating Cytokinesis 1), which facilitates PLK1 recruitment to the 37 
central spindle, was discovered in a proteomic screen of anaphase-arrested HeLa cells (120) 38 
(Figure 2E). At this point in mitosis CDK1 activity is vastly reduced compared to the CDK1 39 
activity present in metaphase, so it was speculated that CDK1 was not the kinase responsible 40 
for generating the phosphoepitope on PRC1 to promote PLK1 binding. Indeed, it was 41 
 10 
determined that PLK1 itself creates the phosphoepitope on PRC1, by phosphorylating Thr602 1 
(120). Interestingly, CDK1 appears to phosphorylate PRC1 on Thr470 and Thr481 in the earlier 2 
stages of mitosis, to inhibit the PLK1-PRC1 interaction until anaphase (120) (Figure 2E). The 3 
kinesin-6 protein MKLP2, discussed earlier in the context of recruitment of the CPC to central 4 
spindle microtubules, also appears to direct PLK1 to the central spindle in anaphase, following 5 
its phosphorylation on Ser528 by PLK1 (Figure 2E) (101). Thus, in the latter stages of mitosis 6 
when CDK1 activity is diminished, the importance of PLK1 in generating the phosphoepitope 7 
on its anchoring proteins to facilitate its PBD binding appears to be much greater. 8 
 9 
The vast array of diverse PLK1 anchoring proteins raises the question of why the cell has 10 
evolved so many diverse PBD-binding proteins. Is it that PLK1 activity at centrosomes, 11 
kinetochores and the central spindle is required at spatially distinct protein complexes within 12 
those mitotic structures? Or is there simply more to the PBD-substrate association 13 
relationship, and each PLK1 anchoring protein is also a PLK1 substrate whose phosphorylation 14 
by PLK1 is critical for centrosome and spindle dynamics? Regardless, targeting PLK1 anchoring 15 
proteins in specific mitotic contexts would allow the disruption of selective PLK1 mitotic 16 
functions, whilst targeting PLK1 kinase activity would be predicted to disrupt all PLK1-17 
dependent mitotic processes. Such a targeted approach may prove powerful when 18 
researching the biology of specific PLK1-containing protein complexes. 19 
 20 
In the case of PLK4, two centrosomal scaffold proteins, Cep152 and Cep192, have been shown 21 
to be required for PLK4 recruitment to centrosomes, as well as for correct centriole 22 
duplication (121, 122). PLK4 differs from PLK1 in that PLK4 harbours a single polo-box at its C-23 
terminus, in addition to a so-called cryptic PBD within the central region of the protein (123). 24 
This cryptic PBD, composed of two pseudo-polo boxes (123), is both necessary and sufficient 25 
for PLK4 targeting to centrosomes, and has been proposed to mediate the interaction 26 
between PLK4 and its binding partners (123, 124). Indeed, it was the cryptic PBD that was 27 
found to bind both Cep192 and Cep152 in a competitive manner, in order to regulate the 28 
recruitment of PLK4 to centrosomes (121, 122). Interestingly, both the PLK4-Cep192 and 29 
PLK4-Cep152 interactions were shown to be regulated in a spatiotemporal manner (121). 30 
However, the molecular basis for these interactions remains to be determined. That said, it is 31 
clear that PLK4 does not adopt the phosphoepitope-binding mechanism that PLK1 employs 32 
to bind its targets. It will be interesting to determine how this cryptic PBD mediates PLK4 33 
recruitment, and if there are more PLK4 anchoring proteins within the centrosome or other 34 
mitotic sites. 35 
 36 
Assembling the Mitotic Checkpoint Complex: all eyes on KNL1 37 
 38 
Named by Lester Sharp in the 1930s, kinetochores are the power-generating business-ends 39 
of chromosomes during mitosis (125). In their capacity to bridge spindle microtubules to 40 
chromosomes, kinetochores are key focal points of phosphorylation-mediated regulation, for 41 
 11 
both the SAC and cell cycle progression (126, 127). The kinases CDK1, PLK1 and AURKB have 1 
all been implicated in the regulation of the SAC and subsequent attachment error correction 2 
(127). However, other kinases have critical roles in the SAC, which are discussed further 3 
herein. 4 
 5 
The transition to anaphase is triggered by the E3 ligase Anaphase-promoting 6 
Complex/Cyclosome (APC/C), which acts to ubiquitinate inhibitors of mitotic exit (Cyclin B) 7 
and of chromosome segregation (Securin), thereby marking them for proteolysis (29, 128). 8 
Thus, when an attachment error is created, the SAC acts to inhibit the APC/C, and in doing so, 9 
prevents the metaphase-to-anaphase transition. The kinetochore-localised multi-protein 10 
complex that is responsible for the inhibition of APC/C in response to attachment error is 11 
called the mitotic checkpoint complex (MCC) (127). The MCC assembles on unattached 12 
kinetochores, and following its assembly, is free to diffuse throughout the cell to inhibit the 13 
APC/C (127). MCC assembly is coordinated by the kinase monopolar spindle 1 (Mps1), and 14 
Mps1 activity drives the recruitment of SAC proteins such as the kinase budding uninhibited 15 
by benzimidazoles 1 (Bub1), the regulatory proteins Bub3, mitotic arrest-deficient 1 (Mad1), 16 
Mad2, and the pseudokinase Bub-related 1 (BubR1) (129-132). Mps1 thus acts as the master 17 
regulator of the SAC. 18 
 19 
Mps1 is activated by autophosphorylation upon its localisation to kinetochores, which is 20 
regulated by AURKB activity, again illustrating some of the crosstalk evident between mitotic 21 
kinases (133-135). Mps1 is then in a prime position to efficiently recruit the MCC, including 22 
the Bub1 kinase. The importance of Bub1 is perhaps best showcased in experiments in yeast, 23 
where deletion of BUB1 in S. pombe increased the rate of chromosome missegregation, and 24 
deletion of BUB1 in S. cerevisiae caused slow growth and chromosome loss (136, 137). Bub1 25 
is also required for the kinetochore localisation of Mad1 and Mad2, following its recruitment 26 
by Mps1 (138).  27 
 28 
Central to the coordinated MCC assembly on unattached kinetochores is the scaffold protein 29 
KNL1 (Kinetochore Scaffold 1) (Figure 3). Through a variety of conserved functional domains 30 
and motifs (139), KNL1 essentially acts as the SAC assembly platform. Following 31 
phosphorylation of KNL1 by Mps1 (Figure 3A), Bub1 and Bub3 directly associate with KNL1 32 
(140-143), and subsequently Bub1 acts to recruit Mad1, Mad2 and BubR1 to the kinetochore 33 
(138, 144) (Figure 3B). Thus, loss of KNL1 disrupts the localisation of all SAC proteins, with the 34 
exception of Mps1. Crucially, disruption of Mps1-dependent KNL1 phosphorylation 35 
attenuates the binding of Bub1 and Bub3 to KNL1, and is accompanied with chromosome 36 
congression and SAC signalling defects (141-143). Mechanistically, Mps1 phosphorylates so-37 
called MELT repeats in KNL1, and these phosphoepitopes facilitate the binding to Bub1 and 38 
Bub3. Bub1 then acts as a scaffold to assemble the remainder of the SAC proteins. Thus, 39 
despite being a kinase, the major role of Bub1 in the SAC appears to be its protein anchoring 40 
function, and not its catalytic activity. However, Bub1 has been linked to the phosphorylation 41 
 12 
and subsequent inhibition of Cdc20, thereby providing a potential mechanistic insight into 1 
how the SAC acts to inhibit the APC/C following chromosome attachment error (145, 146). In 2 
line with such a central role in SAC signalling, KNL1 depletion in HeLa cells was shown to 3 
disrupt SAC-induced mitotic arrest following exposure to microtubule poisons (147). KNL1 is 4 
also required for silencing of the SAC signal to enable the metaphase-to-anaphase transition 5 
once all kinetochores are engaged, although this is beyond the scope of this review and has 6 
been reviewed elsewhere (148).  7 
 8 
Delivery of a pleiotropic kinase to the mitotic spindle: CK1α sets the bar 9 
 10 
The Casein Kinase 1 (CK1) family forms its own distinct branch of the kinome tree (149), and 11 
constitutes one of the first Ser/Thr protein kinase families to be discovered (150). The CK1 12 
branch includes the CK1 isoforms, and the closely-related Vaccinia-related kinases (VRKs), and 13 
Tau Tubulin Kinase 1 (TTBK1) members (149, 151). To date, six mammalian CK1 isoforms, 14 
namely α, γ1, γ2, γ3, δ and ɛ, and their associated splice variants, have been reported based 15 
on their high degree of homology within the kinase domains (152-154). 16 
 17 
The absence of isoform-selective CK1 inhibitors has led to confusion regarding exactly which 18 
CK1 isoform represents the physiological kinase for each of the identified substrates. The 19 
kinase domains of CK1 isoforms (sequence-wise and structurally) are very similar, and all CK1 20 
isoforms are thought to be constitutively active in vitro, capable of phosphorylating substrate 21 
residues conforming to identical motifs (152-154). Due to most cellular proteins harbouring 22 
at least one CK1 consensus phospho-motif, it is perhaps not surprising that hundreds of CK1 23 
substrates have been reported. Added complexity arises when considering the cellular 24 
environment. Indeed, the substrate specificity of CK1 isoforms in vitro is thought to be largely 25 
different from that observed in vivo, and different isoforms are known to impact distinct 26 
biological processes, suggesting tight regulation of distinct isoforms in cells (152-154). This 27 
difference in the in vitro versus in vivo substrate specificity is attributed to intracellular 28 
regulatory mechanisms involved in modulating CK1 isoforms, such as functional binding 29 
partners and post-translational modifications. Furthermore, as the kinase domain of CK1 30 
isoforms constitutes the vast majority of the protein sequence, regulatory domains that are 31 
prevalent in many other kinases are very small, if not completely absent, in CK1 isoforms. This 32 
adds further merit to the need for additional regulatory CK1-binding partners in cells. These 33 
attributes have prompted researchers to ascertain the precise molecular mechanisms by 34 
which the activities of specific CK1 isoforms towards their cellular substrates are governed. 35 
 36 
The S. cerevisiae orthologue of CK1 was among the first kinases identified to have a role in 37 
the regulation of cell cycle progression (155). In mammals however, where there are multiple 38 
CK1 isoforms present, the precise contribution of each isoform to the regulation of the cell 39 
division cycle is not well understood. CK1δ has been found on centrosomes, and displays high 40 
affinity towards microtubules in response to DNA damage, suggesting a possible checkpoint 41 
 13 
role for CK1δ in cell division (156, 157). Furthermore, inhibition of CK1δ/ɛ using the CK1δ/ɛ-1 
specific inhibitor IC261 is accompanied by cell cycle arrest (156). In addition to CK1δ, CK1α 2 
has long been suggested to have a role in mitosis. Early immunostaining efforts identified 3 
CK1α on mitotic spindles (158), and morpholino-mediated knockdown of CK1α triggered 4 
mitotic arrest and chromosomal alignment defects in mouse oocytes (159). However, CK1α 5 
has also been implicated in many other, diverse signalling processes (Figure 4A). 6 
 7 
Recently, the FAM83 family of proteins have emerged as central regulators of CK1 isoforms 8 
in cells (160-162). In the context of cell division, the selective CK1α-binding protein FAM83D 9 
was shown to be absolutely required for CK1α to localise to mitotic spindles (163) (Figure 4B). 10 
Cells devoid of FAM83D, or those harbouring a CK1-binding deficient F283A mutant of 11 
FAM83D, failed to recruit CK1α to the spindle apparatus (163). Concomitantly, these cells 12 
presented with spindle misorientation phenotypes, and exhibited a delay in the metaphase-13 
to-anaphase transition (163). CK1α was shown to regulate the process of spindle positioning, 14 
which is critical for both accurate development and maintenance of healthy adult tissues, in 15 
a manner dependent on its delivery to the spindle by FAM83D (163). As CK1α is known to 16 
regulate many diverse signalling processes, from Wnt signalling to circadian rhythm (153, 17 
164), targeting FAM83D had the added benefit of impacting only one CK1α-specific process, 18 
whilst seemingly not affecting other aspects of CK1α biology – a feat impossible to achieve 19 
with CK1α knockdown or its inhibition with small molecules (Figure 4C). Indeed, the gene 20 
encoding CK1α, CSNK1A1, appears to be an essential gene required for cell viability (165), and 21 
the fact that FAM83D knockout cells are viable would argue that the essential CK1α functions 22 
remain intact following FAM83D ablation.  23 
 24 
Interestingly, a recent phosphoproteomic study reported that roughly 50% of all cell cycle-25 
regulated phosphopeptides conform to the predicted CK1 consensus substrate motifs (6). 26 
Thus, whilst CK1α is only beginning to be considered as a mitotic kinase, there is huge scope 27 
for future efforts aimed at identifying the physiological CK1α substrates in mitosis, and 28 
deciphering how CK1α exerts its regulation on spindle positioning at the molecular level. It is 29 
also noteworthy that, like many cell-cycle regulated anchoring proteins such as Cyclins and 30 
TPX2 (18, 166), FAM83D transcripts and protein levels are regulated during the cell cycle, with 31 
levels rising during mitosis and falling upon mitotic exit, whereas those of CK1α remain 32 
unchanged throughout (163). 33 
 34 
FAM83D itself relies on the non-motor, microtubule-associated protein HMMR (aka RHAMM) 35 
for its recruitment to spindle microtubules (108, 163). Thus, cells devoid of HMMR phenocopy 36 
cells devoid of FAM83D, and present with spindle positioning defects (108, 163). This model 37 
would therefore suggest that CK1α requires both FAM83D and HMMR for its spindle 38 
localisation, and therefore its mitotic function. Why would the cell evolve such a two-pronged 39 
mechanism to recruit CK1α to spindles? Whilst this question still requires some work in terms 40 
of mechanistic and structural insights, it is interesting to note that HMMR has also been 41 
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reported to direct the TPX2-AURKA complex to spindle microtubules in mitosis (55). HMMR-1 
silenced cells presented with a reduction in both TPX2 and active AURKA at mitotic spindles, 2 
and could not establish spindles of the correct length (55) – a phenotype common to cells in 3 
which the AURKA-TPX2 interaction is compromised (58). Mechanistically, HMMR is thought 4 
to participate in the Ran-GTP-dependent microtubule nucleation pathway, and serves to 5 
anchor NEDD1 (Neural precursor cell Expressed Developmentally Down-regulated protein 1) 6 
to promote TPX2-AURKA recruitment to sites of microtubule assembly, where AURKA 7 
phosphorylates NEDD1 on Ser405 (167-169). PLK1-dependent phosphorylation of NEDD1 8 
regulates the recruitment of NEDD1 (170, 171), and HMMR in turn regulates PLK1 activity 9 
(108), implying the potential existence of an HMMR-dependent feedback loop to coordinate 10 
spindle assembly. The AURKA- and CK1α-containing HMMR complexes are likely distinct, as 11 
neither TPX2 nor AURKA were detected in endogenous FAM83D immunoprecipitations 12 
subjected to mass spectrometric analysis (163). Thus, it may transpire that HMMR acts as a 13 
central scaffolding protein to which anchoring proteins like FAM83D and TPX2 associate in 14 
order to direct their associated kinase cargos to distinct locations along the mitotic spindle.  15 
 16 
Conclusions and future perspectives 17 
 18 
Here, we set out to review the diverse modes of regulation bestowed on mitotic kinases by 19 
anchoring proteins. Through the regulation of protein kinase localisation, activity, stability 20 
and/or substrate accessibility, mitotic kinase anchoring proteins have evolved as critical 21 
regulators of mitosis in cells. Whilst research has primarily focussed on the roles and 22 
regulation of the conventional mitotic kinase families mentioned above, it is beginning to be 23 
appreciated that these kinase families alone cannot account for the full extent of protein 24 
phosphorylation that is evident during mitosis (6, 7, 172, 173). Interestingly, a recent 25 
phosphoproteomic study sought to identify and assign cell cycle-regulated phosphopeptides 26 
to known kinases, based on the optimal consensus motifs present within the 27 
phosphopeptides (6). Whilst CDKs and PLKs were identified within the top ten kinase families, 28 
the vast majority of phosphopeptides conformed to the predicted motifs for CK1, Casein 29 
kinase 2 (CK2), Protein Kinase A (PKA) and Glycogen Synthase Kinase 3 (GSK3) (6). Whilst 30 
predicted motifs do not necessarily point to direct roles of the aforementioned kinases per 31 
se, it is interesting to note that mitotic roles for some of these kinases, and others such as 32 
Protein Kinase C (PKC) and the NIMA-related kinases (NEKs), have already been reported 33 
(174-177). In some cases, these kinases have been shown to localise to key mitotic sites, such 34 
as the spindle apparatus and kinetochore. For example, CK2α was shown to localise to mitotic 35 
spindles in both a phosphorylation and PIN1 (Peptidyl-prolyl cis-trans Isomerase NIMA-36 
interacting 1)-dependent manner (178).  37 
 38 
Pleiotropic kinases, which are active throughout the cell cycle, are often more challenging to 39 
study compared with their pure mitotic kinase counterparts, as their inhibition or knockdown 40 
will have consequences beyond just their mitotic functions. In this context, the identification 41 
 15 
of specific anchoring proteins that underpin their mitotic roles will be of paramount 1 
importance in understanding precisely how these kinases contribute to the regulation of the 2 
cell division cycle. Indeed, taking the FAM83D-CK1α interaction mentioned earlier as an 3 
example, being able to manipulate FAM83D-bound CK1α, rather than pan-cellular CK1α 4 
activity, afforded the key advantage of allowing the selective investigation into the role of 5 
CK1α in cell division, whilst seemingly unaffecting the non-mitotic CK1α functions (163). 6 
Uncovering key anchoring proteins that control the subcellular distribution and/or activities 7 
of protein kinases during mitosis will undoubtedly hold promise for differentiating their 8 
mitotic roles from their other non-mitotic functions. Furthermore, in cases such as CDKs, 9 
Aurora kinases, PLK1, and CK1α, for which there are multiple anchoring proteins already 10 
identified, being able to target each anchoring protein in turn will shed light on complex-11 
specific functions of these key mitotic kinases. 12 
 13 
The coordinated cross-talk evident between mitotic kinases, acting in concert to orchestrate 14 
a successful cell division, highlights the importance of kinase signalling networks in driving the 15 
cell cycle. Critical for the success of such finely-tuned cross-talk events are the many 16 
anchoring proteins that serve to spatiotemporally direct the mitotic kinases to their correct 17 
sites of action. For example, and as discussed above, Bora serves to direct AURKA to 18 
centrosomes, where the AURKA-Bora complex activates PLK1, leading to a whole plethora of 19 
downstream responses, including the degradation of Bora through PLK1-mediated Bora 20 
phosphorylation. As a direct consequence, AURKA, now no longer bound to Bora, is free to 21 
bind TPX2 on spindle microtubules and regulate spindle microtubule dynamics. Furthermore, 22 
coupling Histone H3 dephosphorylation and reduced CDK1 activity to the redistribution of the 23 
CPC from chromatin to the central spindle in anaphase, is a great example of how cooperative 24 
phosphorylation events can regulate the subcellular localisation of anchoring proteins, and 25 
hence the associated mitotic kinase. Another example stems from the inhibitory 26 
phosphorylation of PRC1 by CDK1 in the earlier stages of mitosis, to inhibit the PRC1-PLK1 27 
interaction until anaphase when CDK1 activity is reduced.  28 
 29 
Anchoring proteins can also facilitate mitotic kinase cross-talk by acting as the physical bridge 30 
between two or more mitotic kinases and their substrates. In the case of Gravin and Cep192, 31 
these anchoring proteins can bind both PLK1 and AUKA, suggesting that perhaps Gravin and 32 
Cep192 require phosphorylation inputs from both PLK1 and AURKA. Alternatively, Gravin and 33 
Cep192 may act to localise both PLK1 and AURKA in proximity to common substrates, that 34 
function in response to dual phosphorylation from both kinases to coordinate centrosome 35 
maturation. Furthermore, if the latter hypothesis is correct, such phosphorylation inputs do 36 
not necessarily need to be synergistic. These phosphorylation events could be antagonistic or 37 
hierarchical, in order to finetune the downstream biology. In the case of HMMR, although 38 
there is no evidence that HMMR can simultaneously bind both the FAM83D-CK1α and TPX2-39 
AURKA complexes, the sheer spatial proximity of two HMMR complexes (one containing 40 
 16 
HMMR-FAM83D-CK1α and the other containing HMMR-TPX2-AURKA) on the spindle, may be 1 
sufficient to allow cross-talk between CK1α and AURKA on shared substrates.  2 
 3 
Given such evident cross-talk between mitotic kinases, targeting mitotic kinase anchoring 4 
proteins for inhibition may lead to disruption of entire mitotic signalling networks, as opposed 5 
to the ablation of a single specific mitotic kinase complex and its associated function. As such, 6 
anchoring proteins present themselves as novel therapeutic targets in disease. Recent years 7 
have seen the development of so-called PROteolysis TArgeting Chimeras (PROTACs), which 8 
serve to degrade proteins of interest within the cell by directing them to endogenous E3 9 
ubiquitin ligase machinery (179, 180). The fact that some mitotic kinase anchoring proteins, 10 
such as Cyclins and FAM83D, are quickly turned over following mitotic exit, whereas their 11 
interacting kinases are not, not only provides insights into their importance in controlling 12 
protein kinase function during mitosis, but suggest that their premature proteolysis may act 13 
as an effective means of inhibiting mitotic kinase function. Clearly, such information can be 14 
harnessed to target key anchoring proteins for degradation prior to mitosis, which may 15 
facilitate effective disruption of the associated kinase function during mitosis. Such strategies 16 
potentially offer alternative opportunities for therapeutic intervention in diseases such as 17 
cancer, in which control of the cell cycle is compromised.  18 
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Figure Legends: 1 
 2 
Figure 1: Anchoring proteins in the regulation of Aurora kinase localisation: A: AURKA 3 
localises to the centrosomes in a Bora-dependent manner, where Bora acts to facilitate 4 
AURKA-dependent activation of PLK1. As M phase progresses, activated PLK1 phosphorylates 5 
Bora to promote Bora proteolysis, and AURKA associates with TPX2 to facilitate its localisation 6 
to the spindle microtubules. TPX2 serves as an allosteric activator of AURKA. B: AURKB forms 7 
the so-called Chromosome Passenger Complex (CPC), composed of AURKB and three 8 
associated non-enzymatic proteins termed INCENP, Survivin and Borealin. Following Histone 9 
H3 phosphorylation at Thr3 by the Ser/Thr kinase Haspin, Survivin mediates recruitment of 10 
the CPC to chromatin. At anaphase, Histone H3 is dephosphorylated and the CPC relocalises 11 
to the central spindle, through binding the kinesin-6 microtubule-binding protein MKLP2. 12 
Created with BioRender.com. 13 
 14 
Figure 2: The polo-box domain determines the subcellular distribution of PLK1: A: Schematic 15 
overview of PLK1 domain architecture, highlighting the N-terminal kinase domain, which 16 
needs to be activated by an upstream kinase, and the C-terminal Polo-box Domain (PBD), 17 
which binds to phosphorylated epitopes on anchoring proteins to promote PLK1 association 18 
with the anchoring protein. B: PLK1 is activated through phosphorylation of Thr210 by an 19 
upstream kinase, principally thought to be the AURKA-Bora complex. The PBD of PLK1 20 
determines the localisation of PLK1 and its recruitment to substrates, by binding to 21 
phosphorylated anchoring proteins. Such phosphorylated anchoring proteins are 22 
phosphorylated by a priming kinase, most frequently CDK1-Cyclin B or PLK1 itself. C: An 23 
overview of the centrosome-localised PLK1 anchoring proteins: Gravin and Cep192 24 
simultaneously bind PLK1 and AURKA. Whilst Gravin interacts with PLK1 following priming 25 
phosphorylation by CDK1, the Cep192-PLK1 interaction is thought to rely on PLK1-dependent 26 
phosphorylation of Cep192. Cenexin is another example of a centrosome-localised CDK1-27 
dependent PLK1 anchoring protein. D: An overview of kinetochore-localised PLK1 anchoring 28 
proteins: Bub1, CLIP-170 and Dynactin promote PLK1-recruitment to kinetochores in a CDK1-29 
dependent manner. E: An overview of central spindle-localised PLK1 anchoring proteins. 30 
During metaphase CDK1 activity is high, and CDK1-Cyclin B phosphorylates PRC1 on Thr470 31 
and Thr481 to inhibit the association of PRC1 with PLK1. During anaphase, CDK1 activity is 32 
reduced, and PLK1 can phosphorylate PRC1 on Thr602 to promote the PRC1-PLK1 interaction, 33 
and concurrent recruitment of PLK1 to the central spindle. MKLP2 is another central spindle 34 
protein that anchors PLK1 to the central spindle, following PLK1-dependent phosphorylation 35 
of MKLP2 on Ser528. Created with BioRender.com.  36 
 37 
Figure 3: KNL1 facilitates the spindle assembly checkpoint by anchoring the mitotic 38 
checkpoint complex: A: After sensing an unattached kinetochore, the kinase Mps1 39 
phosphorylates MELT repeats on KLN1 to promote downstream assembly of the mitotic 40 
checkpoint complex. B: Following MELT repeat phosphorylation, Bub1 and Bub3 bind to KNL1, 41 
and Bub1 functions to recruit the other Mitotic Checkpoint Complex (MCC) components 42 
Mad1, Mad2 and BubR1 to trigger the Spindle Assembly Checkpoint (SAC). The SAC signal 43 
inhibits chromosome segregation until all chromosomes are correctly attached and 44 
biorientated. Loss of KNL1 leads to mislocalisation of all SAC proteins, with the exception of 45 
Mps1. Created with BioRender.com. 46 
 47 
 28 
Figure 4: Isolating the mitotic kinase activity of a promiscuous kinase: A: CK1α is a Ser/Thr 1 
protein kinase involved in many diverse cellular processes. B: Selective recruitment of CK1α 2 
to spindle microtubules by FAM83D: In interphase, the FAM83D-HMMR complex cannot 3 
associate with CK1α. During mitosis, the FAM83D-HMMR complex localises to spindle 4 
microtubules, and, through as of yet unidentified mechanisms, FAM83D binds CK1α and 5 
recruits it to the mitotic spindle to coordinate proper spindle positioning. CK1α 6 
phosphorylates FAM83D, but the exact relevance of this phosphorylation event is still to be 7 
determined. C: CK1α is a pleiotropic kinase with critical roles in both interphase and mitosis. 8 
Thus, pan-cellular inhibition or knockdown of CK1α will affect all of these processes, and 9 
specific mitotic effects will be hard to infer. Targeting FAM83D, on the other hand, may 10 
present a means to selectively disrupt the mitotic functions of CK1α, without impacting its 11 
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Wnt Signalling Yes Yes ?
Apoptosis Yes Yes ?
Cell Division Yes Yes Yes
DNA Damage Yes Yes ?
p53 Signalling Yes Yes ?
Box 1
Type of Regulatory Protein Description
Adaptor Protein A protein, usually small in size, which serves to link two functional enzymes within a signaling 
cascade. Adaptor proteins usually exploit protein-protein interaction domains to facilitate their 
binding to their associated enzymes.
Anchoring/Scaffold Protein Often used interchangeably, these terms refer to accessory proteins that bind more than two 
signaling components, and are capable of regulating the activity of that protein complex through 
various mechanisms, such as the activation or repression of catalytic activity. Anchoring protein is 
typically used to describe a protein that determines the subcellular localization of the interacting 
partners, whereas scaffold protein is used preferentially when describing a signalosome assembly 
platform. For the purpose of this review, use of the term anchoring protein is principally intended to 
define mitotic kinase interacting proteins that determine the subcellular distribution of the 
interacting mitotic kinases, but this definition does not limit potential additional roles beyond 
determination of subcellular distribution.
Docking Protein Strictly speaking, the term docking protein refers to an accessory protein within a receptor tyrosine 
kinase signaling pathway that is composed of a membrane-targeting domain, a protein-protein 
interaction domain, and an extended region containing many Tyr residues for receptor-mediated 
phosphorylation. 
